01:09 PM EDT, 05/16/2024 (MT Newswires) -- Monte Rosa Therapeutics ( GLUE ) said Thursday it has priced an underwritten offering of common shares and warrants for expected gross proceeds of about $100 million.

The offering consists of 10,638,476 commons shares at $4.70 per share and pre-funded warrants to purchase 10,638,524 common shares $4.6999 per pre-funded warrant to specific investors.

The offering is expected to close around Monday, pending the fulfillment of customary closing conditions.

Monte Rosa shares were down 5% in recent trading.

Price: 4.97, Change: -0.27, Percent Change: -5.07